Circulation: Cardiovascular Interventions

MARCH 9, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. No significant differences were observed in documented arrhythmias, bleeding, or stroke. However, the impact of nickel hypersensitivity on post-procedural outcomes remains poorly understood. Nickel hypersensitivity was assessed using skin patch testing.

Chest Pain 70

Chest Pain Cardiovascular Interventions Document Arrhythmia 70

Circulation: Cardiovascular Interventions

JUNE 4, 2024

Circulation: Cardiovascular Interventions, Ahead of Print.

Aortic valve 40

Aortic valve Cardiovascular Interventions Circulation Aortic 40

Circulation: Cardiovascular Interventions

OCTOBER 22, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. Background:Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Primary outcome was all-cause mortality. 2VB-PVD, HR 1.12; 95% CI, 1.09-1.15,

Aortic valve 40

Aortic valve Aortic TAVR Outcomes 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4142612-A4142612, November 12, 2024. Background:The CHIP score, developed from the BCIS (British Cardiovascular Intervention Society) database, predicts adverse in-hospital MACCE (major adverse cardiovascular and cerebrovascular events). 1.49; score 3-4: HR 1.95, 95% CI 1.62-2.35;

Myocardial Infarction 40

Myocardial Infarction Cardiovascular Interventions Strokes Stroke 40

Circulation: Cardiovascular Interventions

OCTOBER 17, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. Poverall=0.099) and all stroke (30 days: 1.0% BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. In the matched population, differences in mortality (30 days: 4.2%

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic Tricuspid 40

Circulation: Cardiovascular Interventions

MARCH 17, 2025

Circulation: Cardiovascular Interventions, Volume 18, Issue 3 , Page e014899, March 1, 2025. BACKGROUND:Ineligibility for surgical revascularization is increasingly prevalent and associated with increased mortality after percutaneous coronary intervention (PCI).

Coronary Artery Disease 40

Coronary Artery Disease Outcomes Myocardial Infarction Cardiovascular Interventions 40

Circulation: Cardiovascular Interventions

JUNE 10, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. During the follow-up, 12.50% (n=3) all-cause death, 4.17% (n=1) stroke, and 16.67% (n=4) recurrence were seen. 1273.47) days, stroke was 1211.38 (95% CI, 1110.40–1312.35) The study participants were followed up for a median period of 344.50 (65.00–953.75)

Embolism 40

Embolism Bicuspid/Mitral Outcomes Cardiovascular Interventions 40